Sep 2014 to 2000 Administrator AssistantLinden Ponds
Mar 2010 to 2000 Certified Nurses AssistantCopeland Toyota Scion Brockton, MA Aug 2008 to Sep 2013 Office ClerkJ.Derenzo Contracting Brockton, MA Dec 2007 to Mar 2008 Office ClerkBuilding #19 Weymouth, MA Feb 2005 to Dec 2007 Shoe Department and Backup Cashier
Education:
Massasoit Commuinty College Brockton, MA 2005 to 2008 Associates Degree in Travel & Tourism
Fred Hutchinson Cancer Research Center 1100 Fairview Ave N STE D3-100, Seattle, WA 98109 2066674886 (phone), 2066676084 (fax)
Education:
Medical School Harvard Medical School Graduated: 1996
Conditions:
Anemia Leukemia
Languages:
English
Description:
Dr. Delaney graduated from the Harvard Medical School in 1996. She works in Seattle, WA and specializes in Pediatric Hematology-Oncology. Dr. Delaney is affiliated with Seattle Childrens Hospital.
Us Patents
Co-Culture Of Placental Stem Cells And Stem Cells From A Second Source
Mohammad Heidaran - Chatham NJ, US Jia-Lun Wang - Cherry Hill NJ, US Qian Ye - Livingston NJ, US Andrew Zeitlin - Basking Ridge NJ, US Colleen Suzanne Delaney - Seattle WA, US
Assignee:
Anthrogenesis Corporation - Warren NJ
International Classification:
C12N 5/02
US Classification:
435373, 435325, 435366, 435372
Abstract:
The present invention relates to a combination of placental stem cells and stem or progenitor cells derived from a second source, wherein the combination shows improved engraftment as compared to placental stem cells or stem cells from a second source, alone. The combination is referred to as a combined stem cell population. The invention also provides in vitro and in vivo methods for identifying and producing combined stem cell populations, and models of engraftment. In accordance with the present invention, the placental stem cells may be combined with, e. g. , umbilical cord blood-derived stem or progenitor cells, fetal or neonatal stem cells or progenitor cells, adult stem cells or progenitor cells, hematopoietic stem cells or progenitor cells, stem or progenitor cells derived from bone marrow, etc.
News
How umbilical cords are saving the lives of cancer patients
n his arrival to The Hutch in 2009, Milano teamed up with Colleen Delaney, founder and director of the Cord Blood Programme, to test and refine a treatment strategy that may yet prove a better option than a bone marrow transplant for people with leukaemia who are at high risk of relapsing.
Date: Mar 28, 2017
Category: Health
Source: Google
Roberts boosts visibility of bone marrow transplants
"We always call it a bone marrow transplant, but really it is a transplant with blood stem cells," says hematologist-oncologist Colleen Delaney, director of the program in cord blood transplant and research at Fred Hutchinson Cancer Research Center in Seattle.